News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Nano Labs Develops Diagnostic Technology to Identify Tuberculosis (TB) Through Novel Nanotechnologies


3/4/2013 11:42:44 AM

DETROIT, March 4, 2013 (GLOBE NEWSWIRE) -- Nano Labs Corp. (OTCQB:CTLE) is pleased to present industry with promising biological diagnostics test results obtained at macro-level, on a miniaturized tuberculosis biosensor platform.

The Company successfully developed a Point-of-Care biosensor at macro-level and presents industry with proposals for miniaturization and commercialization at large scale. The joint venture proposal is for the development of miniaturized Point-of-Care (PoC) and Lab-on-Chip (LoC) biosensors.


Read at GlobeNewswire

comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES